Squarepoint’s CryoPort CYRX Stock Holding History

Squarepoint’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,700	Closed	-$186K	–	3333
2022 Q4	$186K	Hold	10,700	–	–	﹤0.01%	2811
2022 Q3	$261K	Buy	+10,700	New	+$368K	﹤0.01%	2560

Other funds holding CYRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Squarepoint's CYRX Position: Q2 2026 in Review

Squarepoint increased its CryoPort (CYRX) stake by 685% in Q2 2026, buying an estimated $4.12M and bringing the position to 368,424 shares worth $5.78M. The position accounts for 0.01% of the portfolio, ranked #1493.

Squarepoint first reported a position in CYRX in Q3 2017 and has held it in 20 quarters since. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

Squarepoint held 368,424 shares of CryoPort worth $5.78M as of Q2 2026.
Squarepoint bought 321,497 CryoPort shares in Q2 2026, an estimated $4.12M.
CryoPort made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1493 holding.
Squarepoint first reported a position in CryoPort in Q3 2017 and has held it in 20 quarters since.
185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.